
Scientists identify RYK as a GPNMB receptor driving MASH in mice
A protein called GPNMB and its receptor RYK drive fatty liver disease (MASH) in mice and humans. Blocking this pathway with various treatments effectively prevented and treated MASH in animal models, identifying a promising new therapeutic target.











